| Market Cap | ₹148Cr |
| ROE | 13.86% |
| P/E Ratio(TTM) | 13.68 |
| EPS(TTM) | 9.43 |
| P/B Ratio | 1.78 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.73 |
| Book Value | 72.35 |
| Debt to Equity | 0.84 |
| Face Value | 10 |
| Parent Organisation | Parnax Lab Limited |
| Managing Director | Mr. Baiju Shah |
| BSE Symbol | 506128 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.50 | ||
| Ajanta Pharma | NA (0.00%) | 33.07 | ||
| Gland Pharma | NA (0.00%) | 38.55 | ||
| Eris Lifesciences | NA (0.00%) | 52.89 |